The endocannabinoid system is found throughout the brain and body and plays a key role in everything from memory and learning ...

User engagement in a digital weight-loss program yielded better results in participants taking GLP-1 receptor agonists than ...

Knowing that naloxone works by stalling the µ-opioid receptor in an early, latent state suggests that molecules that can bind more tightly or more selectively to this form of the receptor could be ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Naloxone, also known by the brand name Narcan, is one of the most important drugs in the United States' fight against the opioid crisis. It reverses an opioid overdose nearly instantly, restarting ...

The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an ...

New evidence suggests there may be a critical window for hormone replacement therapy use in women to maintain estrogen levels ...

A new wave of metabolic disease drugs beyond GLP-1 agonists is emerging to address the unmet needs of patients.

From high-tech to surprisingly simple, these picks deliver real results.

Could “fatty” or “starchy” one day become accepted as the sixth basic taste alongside the likes of sweet and salty?

Beneath the surface of your gut lies a vast network of neurons—as many as in your spinal cord. New research from the ...